New and Emerging Rheumatic Diseases, An Issue of Rheumatic Disease Clinics of North America, 1st Edition

.\nIn this issue of Rheumatic Disease Clinics, guest editor Dr. Erin Janssen brings her considerable expertise to the topic of New and Emerging Rheumatic Diseases. Top experts in the field cover issues such as approach to diagnosing in-born errors of immunity; Type I interferonopathies; SOCS1 and immune dysregulation; manifestations of DADA2; COPA syndrome; and more.\nContains 15 relevant, practice-oriented topics including T cell tolerance/Treg defects; gene defects in early onset IBD/colitis; autoimmunity with cytoskeletal d/o - WAS, DOCK8; autoimmune and autoinflammatory neurologic conditions; genes in HLH and that predispose to MAS; mutations in severe COVID/MISC; and more.\nProvides in-depth clinical reviews on new and emerging rheumatic diseases, offering actionable insights for clinical practice.\nPresents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.\nNew and Emerging Rheumatic Diseases, An Issue of Rheumatic Disease Clinics of North America 1st Edition is written by Erin Janssen and published by Elsevier. ISBNs for New and Emerging Rheumatic Diseases, An Issue of Rheumatic Disease Clinics of North America are 9780443131165, 0443131163 and the print ISBNs are 9780443131158, 0443131155.